Candida dubliniensis: An update

Revista Iberoamericana de Micologia

Volumn 16, Issue 2, 1999, Pages 72-76

  Sullivan, Derek J ^a   Moran, Gary ^a   Donnelly, Samantha ^a   Gee, Sarah ^a   Pinjon, Emmanuelle ^a   McCartan, Bernard ^a   Shanley, Diarmuid B ^a   Coleman, David C ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ECHINOCANDIN B; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; TRIAZOLE; VORICONAZOLE;

ANTIBIOTIC RESISTANCE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; FUNGAL GENETICS; FUNGUS IDENTIFICATION; GENOTYPE; NONHUMAN; PHENOTYPE; REVIEW; THRUSH; VIRULENCE;

EID: 0032765280     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Fischer-Hoch SP, Hutwagner L. Opportunistic candidiasis an epidemic of the 1980s Clin Infect Dis 1995; 21:897-904.
2. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996; 9:499-511.
3. Hazen KC. New and emerging yeast pathogens. Clin Microbiol Rev 1995; 8:462-478.
4. Pfaller MA. Nosocomial candidiasis: Emerging species, reservoirs, and modes of transmission. Clin Infect Dis 1996; 22(Suppl. 2):S89-S94.
5. Cooper CR. From bamboo rats to humans: the odyssey of Penicillium marneffei. ASM News 1998; 64: 390-397
6. Gori S, Drouhet E, Gueho E, et al. Mycological, ultrastructural, and experimental aspects of a new dimorphic fungus, Emmonsia pasteuriana sp. nov. isolated from a cutaneous disseminated mycosis in AIDS. J Mycol Med 1998; 8.64-77.
7. Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterisation of a novel species associated with oral candidosis in HIV-infected individuals Microbiology 1995; 141:1507-1521
8. Sullivan D, Bennett D, Henman M, et al. Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients. J Clin Microbiol 1993; 31: 2124-2133.
9. Bikandi J, San Millán R, Moragues MD, et al Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes. J Clin Microbiol 1998; 36: 2428-2433.
10. Boerlin P, Boerlin-Petzold F, Durussel C, et al. Cluster of atypical Candida isolates in a group of human immunodeficiency virus-positive drug users. J Clin Microbiol 1995, 33.1129-1135.
11. Boucher H, Mercure S, Montplaisir S, Lemay G. A novel group I intron in Candida dubliniensis is homologous to a Candida albicans intron. Gene 1996; 180:189-196.
12. Ehe CM, Lott TJ, Reiss E, Morrison CJ Rapid identification of Candida species with species-specific DNA probes J Clin Microbiol 1998; 36:3260-3265.
13. Jabra-Rizk MA, Baqui AA, Kelley JI, Falkler WA, Merz WG, Meiller TF. Identification of Candida dubliniensis in a prospective study of patients in the United States. J Clin Microbiol 1999; 37:321-326.
14. Kirkpatrick WR, Revankar SG, McAtee RK, et al. Dectection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J Clin Microbiol 1998, 36:3007-3012.
15. McCullough M, Ross B, Reade P. Characterization of genetically distinct subgroup of Candida albicans strains from oral cavities of patients infected with human immunodeficiency virus J Clin Microbiol 1995, 33:696-700
16. Meis JF, Ruhnke M, De Pauw BE, Odds FC, Siegert W, Verweij PE. Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. Emerg Infect Dis 1999; 5:150-153.
17. Odds FC, Van Nuffel L, Dams G. Prevalence of Candida dubliniensis isolates in a yeast stock collection J Clin Microbiol 1998; 6:2869-2873
18. Sullivan D, Haynes K, Bille J, et al. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J Clin Microbiol 1997; 35:960-964.
19. Velegraki A, Logotheti M. Presumptive identification of an emerging yeast pathogen: Candida dubliniensis (sp. nov.) reduces 2,3,5-triphenyltetrazolium chloride FEMS Immunol Med Microbiol 1998; 20.239-241.
20. Koehler AP, Chu K-C, Houang ETS, Cheng AFB. Simple, reliable, and cost-effective yeast identification scheme for the clinical laboratory. J Clin Microbiol 1999; 37:422-426.
21. Schoofs A, Odds FC, Colebunders R, Ieven M, Goosens H. Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur J Clin Microbiol Infect Dis 1997, 16:296-300.
22. Pinjon E, Sullivan D, Salkin I, Shanley D, Coleman D. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J Clin Microbiol 1998, 36:2093-2095.
23. Sullivan D, Coleman D. Candida dubliniensis: Characteristics and identification. J Clin Microbiol 1998; 36:329-334.
24. Salkin IF, Pruitt WR, Padhye AA, Sullivan D, Coleman D, Pincus DH. Distinctive carbohydrate assimilation profiles used to identify the first clinical isolates of Candida dubliniensis recovered from the United States. J Clin Microbiol 1998; 36:1467.
25. Pincus DH, Coleman DC, Pruitt WR, et al. Rapid identification of Candida dubliniensis with commercial yeast identification systems. J Clin Microbiol 1999; submitted.
26. Jabra-Rizk MA, Falkler WA, Merz WG, Kelley JI, Baqui AA, Meiller TF. Coaggregation of Candida dubliniensis with Fusobacterium nucleatum. J Clin Microbiol 1999, 37:1464-1468.
27. Timmins EM, Howell SA, Alsberg BK, Noble WC, Goodacre R. Rapid differentiation of closely related Candida species and strains by pyrolysis-mass spectrometry and Fourier transform-infrared spectroscopy. J Clin Microbiol 1998; 36:367-374.
28. Joly S, Pujol C, Rysz M, Vargas K, Soll DR. Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis. J Clin Microbiol 1999; 37:1035-1044.
29. Mannarelli BM, Kurtzman CP. Rapid identification of Candida albicans and other human pathogenic yeasts by using short oligonucleotides in a PCR. J Clin Microbiol 1998; 36:1634-1641
30. Gilfillan GD, Sullivan DJ, Haynes K, Parkinson T, Coleman DC, Gow NAR. Candida dubliniensis: phylogeny and putative virulence factors. Microbiology 1998; 144:829-838.
31. Donnelly SA, Sullivan DJ, Shanley DB, Coleman DC. Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology 1999; 145: 1871-1882
32. Kurzai O, Heinz WJ, Sullivan DJ, Coleman DC, Frosch M, Mühlschlegel FA. Rapid PCR test for discnminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C. albicans. J Clin Microbiol 1999, 37:1587-1590
33. MoCullough MJ, Clemons KV, Stevens DA Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J Clin Microbiol 1999; 37:417-421.
34. Pujol C, Renaud F, Mallie M, de Meeus T, Bastide J-M. Atypical strains of Candida albicans recovered from AIDS patients. J Med Vet Mycol 1997, 35:115-121.
35. Velegraki A, Nicolatau O, Theodoridou M, Mostrou G, Legakis NJ. Paediatric AIDS-related linear gingival erythema: a form of erythematous candidiasis. J Oral Pathol Med 1999; 28:178-182.
36. Coleman DC, Sullivan DJ, Bennett DE, Moran GP, Barry HJ, Shanley DB. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 1997; 11:557-567.
37. Moran GP, Sullivan DJ, Henman MC, et al. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother 1997, 41 617-623.
38. Pfaller MA, Messer SA, Gee S, et al. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents. J Clin Microbiol 1999; 37:870-872.
39. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeast. approved standard M27-A. National Committee or Clinical Laboratory Standards, Wayne, Pa, 1997.
40. Moran GP, Sanglard D, Donnelly SM, Shanley DB, Sullivan DJ, Coleman DC. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis. Antimicrob Agents Chemother 1998; 42:1819-1830.
41. Albertson GD, Niimi M, Cannon RD, Jenkinson HF. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob Agents Chemother 1996; 40:2835-2841.
42. Sanglard D, Kuchler K, Ischer F, Pagani J-L, Monod M, Bille J. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother 1995; 39 2378-2386.